GemVax&KAEL Co.,Ltd. (KOSDAQ: 082270)

Market Cap	411.12B
Revenue (ttm)	63.58B
Net Income (ttm)	-52.51B
Shares Out	39.42M
EPS (ttm)	-1,332.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	125,448
Open	10,160
Previous Close	10,180
Day's Range	10,160 - 10,500
52-Week Range	9,060 - 15,310
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About GemVax&KAEL Co.,Ltd.

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea.

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1998
• Employees: 190
• Stock Exchange: KOSDAQ
• Ticker Symbol: 082270

Financial Performance

In 2023, GemVax&KAEL Co.,Ltd.'s revenue was 72.21 billion, a decrease of -4.74% compared to the previous year's 75.80 billion. Losses were -27.18 billion, 38.6% more than in 2022.